This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Abbott Rapid DX North America LLC, doing business as Alere, a subsidiary of Abbott Laboratories Inc. The BPA, valued at $4,676,479.65, is under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. It has an ultimate completion date of December 31, 2025.
The contract provides for the delivery of Abbott BinaxNOW COVID-19 antigen test cards to VA facilities within the Veterans Integrated Service Network 2. Two task orders have been issued to date, valued at $19,296.96 and $384,532.13, for deliveries through December 2023 and December 2024, respectively. The place of performance is Lockhart, Florida. The contracts are firm fixed price with no small business set-asides used. This supports the VA's ongoing COVID-19 testing and diagnostic needs for veteran healthcare services.
Generated 8/23/24, 4:19 PM